{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:43:55Z","timestamp":1765485835666},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1748-717x-9-187","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T11:24:24Z","timestamp":1409052264000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer"],"prefix":"10.1186","volume":"9","author":[{"given":"Raj S","family":"Rajpara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Schreibmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza J","family":"Stapleford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J","family":"Beitler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin A","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,26]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013, 63: 11-30. 10.3322\/caac.21166","journal-title":"CA Cancer J Clin"},{"key":"1156_CR2","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","volume":"17","author":"K Furuse","year":"1999","unstructured":"Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999, 17: 2692-2699.","journal-title":"J Clin Oncol"},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jnci\/djr325","volume":"103","author":"WJ Curran Jr","year":"2011","unstructured":"Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD: Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011, 103: 1452-1460. 10.1093\/jnci\/djr325","journal-title":"J Natl Cancer Inst"},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","volume":"23","author":"P Fournel","year":"2005","unstructured":"Fournel P, Robinet G, Thomas P, Souquet PJ, Lena H, Vergnenegre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daures JP, Mornex F, Perol M: Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d\u2019Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95\u201301 Study. J Clin Oncol 2005, 23: 5910-5917. 10.1200\/JCO.2005.03.070","journal-title":"J Clin Oncol"},{"key":"1156_CR5","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Auperin","year":"2010","unstructured":"Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP: Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010, 28: 2181-2190. 10.1200\/JCO.2009.26.2543","journal-title":"J Clin Oncol"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jnci\/83.6.417","volume":"83","author":"T Le Chevalier","year":"1991","unstructured":"Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY, Laplanche A: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991, 83: 417-423. 10.1093\/jnci\/83.6.417","journal-title":"J Natl Cancer Inst"},{"key":"1156_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1148\/radiology.213.2.r99nv46530","volume":"213","author":"BA Dwamena","year":"1999","unstructured":"Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL: Metastases from non-small cell lung cancer: mediastinal staging in the 1990s\u2013meta-analytic comparison of PET and CT. Radiology 1999, 213: 530-536. 10.1148\/radiology.213.2.r99nv46530","journal-title":"Radiology"},{"key":"1156_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1148\/radiology.212.3.r99se21803","volume":"212","author":"EM Marom","year":"1999","unstructured":"Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF Jr: Staging non-small cell lung cancer with whole-body PET. Radiology 1999, 212: 803-809. 10.1148\/radiology.212.3.r99se21803","journal-title":"Radiology"},{"key":"1156_CR9","doi-asserted-by":"publisher","first-page":"441.e431","DOI":"10.1016\/j.ijrobp.2010.09.033","volume":"82","author":"J Bradley","year":"2012","unstructured":"Bradley J, Bae K, Choi N, Forster K, Siegel BA, Brunetti J, Purdy J, Faria S, Vu T, Thorstad W, Choy H: A phase II comparative study of gross tumor volume definition with or without PET\/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. Int J Radiat Oncol Biol Phys 2012, 82: 441.e431.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1156_CR10","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1200\/JCO.1999.17.10.3201","volume":"17","author":"JF Vansteenkiste","year":"1999","unstructured":"Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Mortelmans LA, Demedts MG: Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999, 17: 3201-3206.","journal-title":"J Clin Oncol"},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"T Berghmans","year":"2008","unstructured":"Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF Jr, Lafitte JJ, Sculier JP: Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008, 3: 6-12. 10.1097\/JTO.0b013e31815e6d6b","journal-title":"J Thorac Oncol"},{"key":"1156_CR12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1118\/1.2868778","volume":"35","author":"CT Badea","year":"2008","unstructured":"Badea CT, Schreibmann E, Fox T: A registration based approach for 4D cardiac micro-CT using combined prospective and retrospective gating. Med Phys 2008, 35: 1170-1179. 10.1118\/1.2868778","journal-title":"Med Phys"},{"key":"1156_CR13","doi-asserted-by":"publisher","first-page":"011702","DOI":"10.1118\/1.4769114","volume":"40","author":"N Kirby","year":"2013","unstructured":"Kirby N, Chuang C, Ueda U, Pouliot J: The need for application-based adaptation of deformable image registration. Med Phys 2013, 40: 011702. 10.1118\/1.4769114","journal-title":"Med Phys"},{"key":"1156_CR14","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1118\/1.2192581","volume":"33","author":"T Li","year":"2006","unstructured":"Li T, Thorndyke B, Schreibmann E, Yang Y, Xing L: Model-based image reconstruction for four-dimensional PET. Med Phys 2006, 33: 1288-1298. 10.1118\/1.2192581","journal-title":"Med Phys"},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1200\/JCO.2009.27.1205","volume":"28","author":"JD Bradley","year":"2010","unstructured":"Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H: Primary analysis of the phase II component of a phase I\/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. J Clin Oncol 2010, 28: 2475-2480. 10.1200\/JCO.2009.27.1205","journal-title":"J Clin Oncol"},{"key":"1156_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ijrobp.2006.02.046","volume":"65","author":"SE Schild","year":"2006","unstructured":"Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J: Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 65: 1106-1111. 10.1016\/j.ijrobp.2006.02.046","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1156_CR17","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1200\/JCO.2007.14.7371","volume":"26","author":"MA Socinski","year":"2008","unstructured":"Socinski MA, Blackstock AW, Bogart JA, Wang X, Munley M, Rosenman J, Gu L, Masters GA, Ungaro P, Sleeper A, Green M, Miller AA, Vokes EE: Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol 2008, 26: 2457-2463. 10.1200\/JCO.2007.14.7371","journal-title":"J Clin Oncol"},{"key":"1156_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/JTO.0b013e31818b1971","volume":"3","author":"TE Stinchcombe","year":"2008","unstructured":"Stinchcombe TE, Lee CB, Moore DT, Rivera MP, Halle J, Limentani S, Rosenman JG, Socinski MA: Long-term follow-up of a phase I\/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA\/B non-small cell lung cancer. J Thorac Oncol 2008, 3: 1279-1285. 10.1097\/JTO.0b013e31818b1971","journal-title":"J Thorac Oncol"},{"key":"1156_CR19","volume-title":"J Clin Oncol","author":"JD Bradley","year":"2013","unstructured":"Bradley JD, Paulus R, Komaki R, Masters GA, Forster K, Schild SE, Bogart J, Garces YI, Narayan S, Kavadi V, Nedzi LA, Michalski JM, Johnson D, MacRae RM, Curran WJ, Choy H: A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Chemoradiotherapy With or Without Cetuximab for Stage III non-Small Cell Lung Cancer: Results on Radiation Dose in RTOG 0617. J Clin Oncol 2013., 31: (suppl; abstr 7501) Abstract Presentation. ASCO 2013"},{"key":"1156_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ijrobp.2012.11.011","volume":"85","author":"J Feddock","year":"2013","unstructured":"Feddock J, Arnold SM, Shelton BJ, Sinha P, Conrad G, Chen L, Rinehart J, McGarry RC: Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2013, 85: 1325-1331. 10.1016\/j.ijrobp.2012.11.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1156_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/JTO.0000000000000031","volume":"9","author":"A Takeda","year":"2014","unstructured":"Takeda A, Sanuki N, Fujii H, Yokosuka N, Nishimura S, Aoki Y, Oku Y, Ozawa Y, Kunieda E: Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy. J Thorac Oncol 2014, 9: 65-73. 10.1097\/JTO.0000000000000031","journal-title":"J Thorac Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-9-187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:46:39Z","timestamp":1630561599000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-9-187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-9-187","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,26]]},"assertion":[{"value":"12 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"187"}}